What does the RightMed® test cover?
Based on DNA analysis, this test determines how your body metabolizes and responds to certain drugs. This test covers the analysis of 25 genes that affect the metabolism and pharmacological response of over three hundred drugs used as therapy for a number of medical conditions. The RightMed® test helps your physician to choose the best medication for you precisely, individualized and most effectively, thus reducing the occurrence of unwanted side effects on the drug and the ineffectiveness of the therapeutic response to that medication. Having in mind the test analyzes your DNA, which is not subject to change, this particular test will help physicians determine your therapy both in this moment and in the future.
The RightMed® test also analyzes genes encoding coagulation factors (Factor II and Factor V) and methylene tetrahydrofolate reductase (MTHFR), which at the same time predicts your genetic risk for thromboembolic events (deep vein thrombosis, pulmonary embolism) that may have serious consequences.
The RightMed® test is conducted at the St. Catherine Specialty Hospital in a very simple way by taking a swab of the patient's buccal mucosa (inner side of the cheek), and the results based on the unique genetic profile of each individual are submitted to your physician who will interpret them and prescribe targeted therapy.
The test analyzes the genes responsible for the metabolism of drugs used to treat:
- ACUTE MIGRAINES
- ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)
- ALZHEIMER’S DISEASE
- BACTERIAL INFECTIONS
- BENIGN PROSTATIC HYPERPLASIA
- CHRONIC HEPATITIS C
- FUNGAL INFECTIONS
- GASTROESOPHAGEAL REFLUX DISEASE (GERD)
- HIV INFECTION
- OVERACTIVE BLADDER
- PARKINSON’S DISEASE
- RHEUMATOID ARTHRITIS
- EPILEPTIC SEIZURES
- SLEEP DISORDERS
- SMOKING ADDICTION